Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Minerva Neurosciences Inc (NASDAQ:NERV)

5.25
Delayed Data
As of 4:00pm ET
 +0.05 / +0.96%
Today’s Change
4.80
Today|||52-Week Range
14.15
-55.32%
Year-to-Date
No recent news for Minerva Neurosciences Inc.

Today’s Trading

Previous close5.20
Today’s open5.30
Day’s range5.20 - 5.40
Volume135,374
Average volume (3 months)210,404
Market cap$201.2M
Dividend yield--
Data as of 4:00pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)+14.66%
Earnings growth (this year)-24.75%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.29-3.29%
ADXSAdvaxis Inc-0.11-3.45%
IMDZImmune Design Corp-0.23-5.11%
URGNUrogen Pharma Ltd+0.80+1.95%
Data as of 4:00pm ET, 11/20/2017

Financials

Next reporting dateMarch 12, 2018
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$0.00
Annual profit (last year)-$31.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rémy Luthringer
Chief Operating Officer &
Senior Vice President
Joseph Reilly
Corporate headquarters
Waltham, Massachusetts

Forecasts